Scientists use skin and blood to create 'Disease in a Dish' for genetic research
NCT ID NCT03612310
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study collects small samples of skin, blood, or urine from people with genetic diseases and healthy volunteers. Researchers will turn these samples into stem cells that can grow into any cell type, like neurons or heart cells. The goal is to develop reliable lab methods to study diseases and test new treatments, without using animals or simple cell models.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how we study genetic diseases in the lab, potentially speeding up drug discovery and understanding of disease mechanisms.
- What could go wrong
- This is an early-stage protocol development study, not a treatment trial. It may not lead to direct patient benefits, and results depend on overcoming technical challenges in stem cell differentiation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENETIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alba Science
RECRUITINGEdinburgh, Midlothian, EH1 3RH, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive global registry aims to unlock secrets of rett syndrome
- Biobank aims to unlock genetic secrets of rare diseases
- Common antibiotic could tame rare calcium disorder
- New study maps developmental milestones in babies with rare genetic conditions
- Genetic detective study aims to solve medical mysteries for 1,000 undiagnosed patients
- 12,000-Person study aims to unlock genetic secrets of rare diseases